PreCyte Inc. is a biotech startup that develops innovative diagnostic tests for neurodegenerative diseases and cancer in Seattle, WA. PreCyte is developing a novel blood-based diagnostic platform to identify disease signatures in patient’s blood. The platform is based on exposing standardized cultured cells to patient’s blood and measuring the transcriptional response of the cells to identify biomarkers of disease. ©